BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
92.55
-0.25 (-0.27%)
Aug 11, 2026, 10:07 AM EDT - Market open
BioNTech SE Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 23,249 | 23,926 | 27,345 | 25,090 | 36,536 | 62,522 | |
Market Cap Growth | -13.39% | -12.50% | 8.99% | -31.33% | -41.56% | 217.55% |
Enterprise Value | 8,228 | 6,785 | 10,145 | 7,038 | 21,677 | 60,506 |
Last Close Price | 92.55 | 95.20 | 113.95 | 105.54 | 150.22 | 257.80 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 24.93 | 3.71 | 5.72 |
Forward PE | - | 100.62 | 100.62 | 67.81 | 8.27 | 8.07 |
PEG Ratio | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
PS Ratio | 7.70 | 6.68 | 9.09 | 5.78 | 1.97 | 2.90 |
PB Ratio | 1.15 | 1.06 | 1.35 | 1.12 | 1.70 | 4.62 |
P/TBV Ratio | 1.46 | 1.33 | 1.50 | 1.34 | 1.89 | 5.73 |
P/FCF Ratio | 43.07 | 72.60 | - | 4.43 | 2.57 | 72.14 |
P/OCF Ratio | 29.73 | 44.72 | 126.52 | 4.23 | 2.51 | 61.80 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.74 | 1.89 | 3.37 | 1.62 | 1.17 | 2.80 |
EV/EBITDA Ratio | - | - | - | 7.29 | 1.58 | 3.46 |
EV/EBIT Ratio | - | - | - | 9.22 | 1.60 | 3.48 |
EV/FCF Ratio | 15.32 | 20.59 | - | 1.24 | 1.53 | 69.81 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Debt / EBITDA Ratio | - | - | - | 0.25 | 0.02 | 0.02 |
Debt / FCF Ratio | 0.67 | 0.95 | - | 0.04 | 0.02 | 0.40 |
Net Debt / Equity Ratio | -0.81 | -0.76 | -0.85 | -0.81 | -0.69 | -0.15 |
Net Debt / EBITDA Ratio | 10.97 | 14.29 | 16.26 | -18.69 | -1.08 | -0.11 |
Net Debt / FCF Ratio | -30.82 | -52.01 | 209.76 | -3.19 | -1.05 | -2.33 |
Asset Turnover | 0.11 | 0.14 | 0.13 | 0.17 | 0.89 | 2.09 |
Inventory Turnover | 6.15 | 3.26 | 1.69 | 1.50 | 6.36 | 10.28 |
Quick Ratio | 7.67 | 7.38 | 7.24 | 9.04 | 7.19 | 4.15 |
Current Ratio | 7.85 | 7.54 | 7.45 | 9.43 | 7.43 | 4.33 |
Return on Equity (ROE) | -9.12% | -5.88% | -3.36% | 4.62% | 59.06% | 155.18% |
Return on Assets (ROA) | -9.76% | -6.82% | -5.67% | 2.34% | 47.09% | 115.21% |
Return on Invested Capital (ROIC) | -53.94% | -40.53% | -37.96% | 10.70% | 112.81% | 201.34% |
Return on Capital Employed (ROCE) | -10.44% | -7.05% | -6.42% | 3.35% | 77.38% | 217.38% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | - | - | - | 4.01% | 26.97% | 17.48% |
FCF Yield | 2.32% | 1.38% | - | 22.57% | 38.90% | 1.39% |
Dividend Yield | - | 0.00% | 0.00% | 0.00% | 1.42% | 0.00% |
Payout Ratio | - | 0.00% | 0.00% | 0.00% | 5.13% | 0.00% |
Buyback Yield / Dilution | -3.00% | -0.54% | 0.95% | 2.84% | 3.81% | -4.51% |
Total Shareholder Return | -3.00% | -0.54% | 0.95% | 2.84% | 5.23% | -4.51% |